Literature DB >> 11932435

Specific incorporation of heat shock protein 70 family members into primate lentiviral virions.

Cagan Gurer1, Andrea Cimarelli, Jeremy Luban.   

Abstract

To determine if any heat shock proteins are incorporated into human immunodeficiency virus type 1 (HIV-1) virions in a manner similar to that of the peptidyl-prolyl isomerase cyclophilin A, we probed purified virions with antibodies against heat shock proteins Hsp27, Hsp40, Hsp60, Hsp70, Hsc70, and Hsp90. Of these proteins, Hsp60, Hsp70, and Hsc70 associated with virions purified based on either particle density or size and were shown to be incorporated within the virion membrane, where they were protected from digestion by exogenous protease. Virion incorporation of Hsp70 was also observed with HIV-2 and with simian immunodeficiency viruses SIV(MAC) and SIV(AGM), but it appears to be specific for primate lentiviruses, since Hsp70 was not detected in association with Moloney murine leukemia virus virions. Of the HIV-1 genes, gag was found to be sufficient for Hsp70 incorporation, though Hsp70 was roughly equimolar with pol-encoded proteins in virions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932435      PMCID: PMC155079          DOI: 10.1128/jvi.76.9.4666-4670.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Molecular chaperones in cellular protein folding.

Authors:  F U Hartl
Journal:  Nature       Date:  1996-06-13       Impact factor: 49.962

2.  HIV-1 Gag protein associates with F-actin present in microfilaments.

Authors:  O Rey; J Canon; P Krogstad
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

3.  In vivo and in vitro association of hsc70 with polyomavirus capsid proteins.

Authors:  T P Cripe; S E Delos; P A Estes; R L Garcea
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.

Authors:  J Hu; C Seeger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  An Hsp60 related protein is associated with purified HIV and SIV.

Authors:  S R Bartz; C D Pauza; J Ivanyi; S Jindal; W J Welch; M Malkovsky
Journal:  J Med Primatol       Date:  1994 Feb-May       Impact factor: 0.667

6.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain.

Authors:  D E Ott; L V Coren; D G Johnson; R C Sowder; L O Arthur; L E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  1995-09       Impact factor: 2.205

8.  Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.

Authors:  P Gallay; V Stitt; C Mundy; M Oettinger; D Trono
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 9.  Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandins.

Authors:  M G Santoro
Journal:  Experientia       Date:  1994-11-30

10.  A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system.

Authors:  J R Lingappa; R L Hill; M L Wong; R S Hegde
Journal:  J Cell Biol       Date:  1997-02-10       Impact factor: 10.539

View more
  62 in total

1.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.

Authors:  Réjean Cantin; Sylvie Méthot; Michel J Tremblay
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.

Authors:  Cagan Gurer; Lionel Berthoux; Jeremy Luban
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Inhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426.

Authors:  Kaboutar Babaahmady; Wulf Oehlmann; Mahavir Singh; Thomas Lehner
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex.

Authors:  Xiaogang Cheng; Michael Belshan; Lee Ratner
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

6.  A role for molecular chaperone Hsc70 in reovirus outer capsid disassembly.

Authors:  Tijana Ivanovic; Melina A Agosto; Kartik Chandran; Max L Nibert
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

7.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

8.  Composition of pseudorabies virus particles lacking tegument protein US3, UL47, or UL49 or envelope glycoprotein E.

Authors:  Kathrin Michael; Barbara G Klupp; Thomas C Mettenleiter; Axel Karger
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.

Authors:  Sergey Iordanskiy; Yuqi Zhao; Larisa Dubrovsky; Tatiana Iordanskaya; Mongzhong Chen; Dong Liang; Michael Bukrinsky
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Hsp70 interacts with the retroviral restriction factor TRIM5alpha and assists the folding of TRIM5alpha.

Authors:  Chae Young Hwang; Jens Holl; Devi Rajan; Younglang Lee; Susan Kim; Moonkyoung Um; Ki-Sun Kwon; Byeongwoon Song
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.